A survey of over 1,000 breast cancer patients prescribed endocrine therapy sheds light on low adherence.

by Emma Yasinski

COVID-19 slowed or stopped enrollment in some cancer clinical trials.

by Kate Yandell

Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.

by Kate Yandell

Data shed light on risk factors for death among people with cancer infected with the coronavirus.

by Kate Yandell

Researchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus.

by Bradley Jones

At the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis.

by Kate Yandell

For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.

by Cheryl Platzman Weinstock

People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.

by William G. Nelson, MD, PhD

Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.

by Anna Azvolinsky

Policy Matters

Cancer outcomes are changing for the better, but advances are not affecting all patients equally.

by Brian Rivers, PhD